
Core Viewpoint - A securities class action lawsuit has been filed against Tempus AI, Inc. for failing to disclose material information, with a deadline for lead plaintiff applications set for August 12, 2025 [1][3]. Company Overview - Tempus AI, Inc. is facing allegations related to violations of federal securities laws during the class period from August 6, 2024, to May 27, 2025 [1][3]. Legal Context - The lawsuit is currently pending in the United States District Court for the Northern District of Illinois, with the case titled Shouse v. Tempus AI, Inc., et al., No. 25-cv-06534 [1][5]. Allegations - The allegations against Tempus include: - CEO Eric Lefkofsky and associates have a history of cashing out before public shareholders incur losses [4]. - The company's AI capabilities are claimed to be overstated [4]. - Board members and executives have connections to companies with restated financial results [4]. - Signs of aggressive accounting and financial reporting practices are present [4]. - Issues with the AstraZeneca and Pathos AI deal warrant scrutiny [4]. - Recent financial guidance revisions indicate weaknesses in core operations [4]. Market Reaction - Following the news of the lawsuit and allegations, Tempus' share price dropped by $12.67, or 19.23%, from $65.87 to $53.20 on May 28, 2025 [5]. Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing the investors in this case, with a strong track record in recovering investment losses due to corporate fraud [5].